Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy.
Sebastian NT, Goyal S, Liu Y, Dhere V, Jani AB, Hershatter B, Patel PR, Shelton JW, Hanasoge S, Godette KD, Patel SA. Sebastian NT, et al. Among authors: hershatter b. J Contemp Brachytherapy. 2024 Aug;16(4):268-272. doi: 10.5114/jcb.2024.143130. Epub 2024 Sep 12. J Contemp Brachytherapy. 2024. PMID: 39628817 Free PMC article.
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Patel SA, Shelton JW, Hanasoge S, Patel PR, Sebastian NT, Adediran OA, Lawal IO, Jani AB. Dhere VR, et al. Among authors: hershatter bw. Pract Radiat Oncol. 2024 Nov-Dec;14(6):e492-e499. doi: 10.1016/j.prro.2024.05.011. Epub 2024 Jul 20. Pract Radiat Oncol. 2024. PMID: 39032598 Clinical Trial.
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
Sebastian N, Goyal S, Liu Y, Janopaul-Naylor JR, Patel PR, Dhere VR, Hanasoge S, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck B, Patel SA. Sebastian N, et al. Among authors: hershatter b. JAMA Netw Open. 2023 Aug 1;6(8):e2327637. doi: 10.1001/jamanetworkopen.2023.27637. JAMA Netw Open. 2023. PMID: 37552479 Free PMC article.
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.
Krauss DJ, Karrison T, Martinez AA, Morton G, Yan D, Bruner DW, Movsas B, Elshaikh M, Citrin D, Hershatter B, Michalski JM, Efstathiou JA, Currey A, Kavadi VS, Cury FL, Lock M, Raben A, Seaward SA, El-Gayed A, Rodgers JP, Sandler HM. Krauss DJ, et al. Among authors: hershatter b. J Clin Oncol. 2023 Jun 10;41(17):3203-3216. doi: 10.1200/JCO.22.02390. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104748 Free PMC article.
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker VM, Olson AC, Cury FL, Papagikos MA, Karrison TG, Sandler HM, Bruner DW. Movsas B, et al. Among authors: hershatter bw. J Clin Oncol. 2023 Jun 10;41(17):3217-3224. doi: 10.1200/JCO.22.02389. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104723 Free PMC article. Clinical Trial.
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Lawal IO, Marcus C, Schuster DM, Goyal S, Adediran OA, Dhere VR, Joshi SS, Abiodun-Ojo OA, Master VA, Patel PR, Fielder B, Goodman M, Shelton JW, Kucuk O, Hershatter B, Halkar RK, Jani AB. Lawal IO, et al. Among authors: hershatter b. Clin Nucl Med. 2023 Apr 1;48(4):e153-e159. doi: 10.1097/RLU.0000000000004590. Epub 2023 Feb 8. Clin Nucl Med. 2023. PMID: 36754362 Free PMC article.
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
Lawal IO, Jani AB, Adediran OA, Goyal S, Abiodun-Ojo OA, Dhere VR, Marcus CV, Joshi SS, Master VA, Patel PR, Goodman M, Shelton JW, Kucuk O, Hershatter B, Fielder B, Halkar RK, Schuster DM. Lawal IO, et al. Among authors: hershatter b. J Nucl Med. 2023 Apr;64(4):586-591. doi: 10.2967/jnumed.122.264832. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328489 Free PMC article.
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Rossi PJ, Shelton JW, Patel PR, Jani AB. Dhere VR, et al. Among authors: hershatter bw. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1003-1014. doi: 10.1016/j.ijrobp.2022.04.005. Epub 2022 Apr 11. Int J Radiat Oncol Biol Phys. 2022. PMID: 35417762 Clinical Trial.
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Fischer-Valuck BW, Patel SA, Brenneman RJ, Christodouleas J, Sargos P, Kim E, Weiss A, Hershatter B, Rao YJ, Picus J, Roth B, Arora V, Carmona R, Reimers M, Zaghloul MS, Gay H, Michalski JM, Baumann BC. Fischer-Valuck BW, et al. Among authors: hershatter b. Eur Urol Oncol. 2022 Apr;5(2):246-250. doi: 10.1016/j.euo.2022.02.001. Epub 2022 Mar 3. Eur Urol Oncol. 2022. PMID: 35249864 Free PMC article.
22 results